Plethico Pharmaceuticals Ltd Nine Monthly Results

Gross Sales

644.35

1,382.73

1,159.91

1,211.86

1,104.75

Excise Duty

0

0

0

0

0

Net Sales

644.35

1,382.73

1,159.91

1,211.86

1,104.75

Other Operating Income

7.94

96.66

16.52

8.51

0

Other Income

0.15

1.53

39.4

0.25

12.97

Total Income

652.44

1,480.94

1,215.83

1,220.64

1,117.72

Total Expenditure

531.66

1,308.71

958.29

1,003.08

850.36

PBIDT

120.78

172.22

257.54

217.55

267.35

Interest

99.95

73.36

43.68

24.48

22.54

PBDT

20.83

98.87

213.86

193.07

244.82

Depreciation

41.48

21.02

13.86

13.94

14.42

Minority Interest Before NP

0

0

0

0

0

Tax

-8.6

-0.75

23.27

10.92

12.46

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-12.05

78.59

176.72

168.19

217.94

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-12.05

78.59

176.72

168.19

217.94

Extra-ordinary Items

0

-57.08

34.79

-30.07

11.96

Adjusted Profit After Extra-ordinary item

-12.05

135.68

141.93

198.27

205.98

EPS (Unit Curr.)

-3.54

23.06

51.88

49.36

63.97

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

34.07

34.06

34.06

34.06

34.06

Public Shareholding (Number)

96,45,975

78,55,622

57,82,622

44,26,667

44,26,667

Public Shareholding (%)

28.31

23.05

16.96

12.98

12.98

Pledged/Encumbered - No. of Shares

2,09,37,385

2,27,32,000

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

85.74

86.73

0

0

0

Pledged/Encumbered - % in Total Equity

61.46

66.73

0

0

0

Non Encumbered - No. of Shares

34,83,307

34,79,045

0

0

0

Non Encumbered - % in Total Promoters Holding

14.26

13.27

0

0

0

Non Encumbered - % in Total Equity

10.22

10.21

0

0

0

PBIDTM(%)

18.74

12.45

22.2

17.95

24.2

PBDTM(%)

3.23

7.15

18.43

15.93

22.16

PATM(%)

-1.87

5.68

15.23

13.87

19.72